>> my mission is simple, to make you money. i'm here to level the playing field for all investors. there's always a bull market somewhere and i promise to help you find it. "mad money" starts now! hey, i'm cramer. welcome to "mad money." welcome to cramerica. other people want to make friends, i'm trying to save you some money. my job is not necessarily to intertain but to teach you, call me or tweet me @jimcramer. it doesn't matter right now. it doesn't mantz how your company is doing or how bright its prospects look. good news of high quality stocks

go down less than others. everything is being brought low by the gravitational pol pull of weakness and fear world wide t. dow plungeing 262 point for closing and reversing down 79 points while the s&p declined 4.3% and the nasdaq fem just 4.73%. we've got some first class information, as etell ceos, you need to stop taking the losses personally. look the market stinks. it might keep stinking until it goes lower. all the weak hands that keep expecting something better finally capitulate. let me give you concrete examples of pasta that don't seem to mean jack in this mark. so you can stop being so

frustrated by the action. first, have you noticed the horrendous problems of volkswagon is spilling over to stocks of auto makers. there is some concerns bmw might have emission problems. what's bad for the goose is good for the gander. and in this case, that's every other automobile company on earth. come on. bmw has to be in total disarray. there is snow way its sales can hold up at all. will it stop people from buying cars? no, it will stop people from buying volkswagons, especially if it's taking different action in different companies. >> that means more for everyone else in the industry. how can this hurt ford, toyota or fiat? the others are challenged, they're global, that i have latin american business and chinese businesses, those businesses are terrible. still, it's nuts to the that people will stop buying cars bus

vw ricked the emissions test. some people will care at some point. second example, boeing, just one $38 billion from various airlines for 300 planes? did you know the aircraft they order is the most lucrative in boeing's product line? as we learn from the former ceo, i can't believe i sister to say former, jim, i'll will listening to you on a visit to boeing exhibit to new orleans. i didn't care about the weak jyuan. even if boeing sank nearly 2 buck, at one time it was down a whole lot more. one day it will matter. it doesn't matter now. how about yield protection, remember that? when a stock goes so low, it stops the selling because it becomes so attractive because of low yielding bonds. if you own a higher yielding stock, whether it be oil and

gas, whoa, or food or beverage the yield has ceased to protect you. just ceased, another sign the bear is growling. these stocks are no longer acting as ball market equivalents, it's not because we fear the fed. we fear falling stocks, consider merck, down 11% for the year. normally you would think that would amount to a safety net for the stock. but what's really going on here is not that rates are going higher, although some people interpret it that way. it's a recognition that merck's 3.5 yield means nothing in the face of a 5 or 10% decline, even from these levels the stocks have been completely clubbed. you have to figure, that itself the cat yp you will sell if you sell the stock. i feel the same about kraft heinz, kirkuk many restructures ahead, it's in control of the king of the structuring, the brutal people from brazil, my charitable trust owns a

considerable amount in kraft heinz precisely for that restructuring. you know i didn't think the stock's 3 morris yield would be so little. little at all. unlike caterpillar's disastrous news, more on that later, cummings has some on the down side the yield hasn't stopped the terrific engine maker stock, which is down 23% for the year, boo! >> i can make the compact same case for emerson and eden, heavy equipment companies that simply aren't that bad. nobody cares and i'm not going to sell. nobody cares enough not to sell. do you remember the 4% yield thark think these stocks are headed so much lower. they don't normally offset the juicy number they grow at ut. it's not mattering. only procter & gamble, which has been sticky seems to be found buyers when it gets to that $70 level. i think in part because high quality blue chips is down 22% going in.

so people think it's okay. here's the problem. the whole problem as i see it right now, unlike 2009, there is no accidental high yield protection. even as the earnings, cash flow and buybacks this time are much more robust tan 2009 and none of these companies is truly dividend challenged. now, look, things can change. they can report a big number. maybe tomorrow is different. i got to tell you something. overall, the action, it's a case for a lower stockmarket. stocks have slipped enough that the yield is fathomable. we haven't gotten there yet. right now the yield protection isn't the price of recognition, it's so necessary, when we buy something that's supposed to act like a bond. you don't necessarily get your money back. finally, there are companies with tremendous earnings that nobody cares about. again, i referenced we had a great number in the j book. so this could change tomorrow. let's just talk about the last few days. you know six companies reported earlier, two food giants, conagra- and general mills, auto

zone, the second largest home builder, lennar and cruise giant carnival. did you know that every one of these companies reported simply spectacular earning, like you saw. general mills gave you sharply better than expected numbers. conagra- gave you a bigger beef. i couldn't believe how good those company's earnings were. auto zone has much more same sales stores than anybody thought. you know i like that stock, recommended it in the game plan, lower gasoline prices had a direct and positive impact on seas, so you can only expect better numbers down the line, given how low oil is. darden gave you stellar numbers top and bottom. best same stores data i can recall. not just olive garden, longhorn and steakhouse were superb. i can't believe lennar are reporting multiple years of trick numbers. judgeing by the land and stingy

credit. i think the housing will be tight and that's an ideal time to buy lennar stock. look at the ceo of carn vam, he's been on the show. he put up gigantic earnings, he is engineered to turn around the worst publicity. carnivale is getting there, the business in europe and even china, nothing short of remarkable. no one paid attention. do you know what happened after almost every single one of those terrific quarters? the stocks went down. in some case, they were the biggest declineers of the day. only general mills really held up and that's because it tends to be less volatile and has a steady dividend boost philosophy that got even more credence after it sold green giant and was served to b & g foods for a tiny time. what's my conclusion? it's pretty simple. right now, fed or no feds. stop talking about the fed

police. it doesn't matter how spectacular your company's results are. investors are selling the good with the bad. it won't always business like this. but we don't know how low the market has to go, in general, before people feel the opportunity is greater than the risk. so here's the bottom line. it's happening to all stocks. we get reprieves, but they're often sucker reprieves. one day they won't be. we haven't yet reached that day. we still need to go lower. so i say, be patient. rationality will, once again, rule. just not here. not now. let's go to cory in massachusetts. cory. >> caller: jim, thanks for having me on. i want to say, i love this show, thank you, thank you, thank you, for everything that you do for all of us. >> oh, thank you. we had a very tough stretch. we always hope things will get better. looking up now, nike after the close. we bot the j-build going up. nike bounced up. i keep telling you, we got to be very, very careful. how can i help? smr jim, i have two questions.

my first question for sui about hillary clinton's recent proposal at the biotech. what's your take on that? then my second question is on horizon pharma. given the recent downturn in the biotech sector, don't you think this stock is still a good fundamental buy? >> horizon of late has raised the price of certain scruggs and they know they can call get away with it, meaning the market can pay the price. i don't think hillary clinton will be that successful overall in trying to curtail drug pricing if she becomes president. but it is a big publicity, let's say, negative and it can, it's got a headline risk is the way i describe it. horizon has more headline rick than any of the other drug companies i follow. ki go to brian in nevada, please, brian. >> hi, jim, i want to secure your perspective on the valuation of super value. with or without the potential

spin-off of save a lot stores. >> you know, we have looked at this, jack moore and i the research director of my charitable trust. we have looked at it. we agree with you. we think it's very inexpensive. in the end remember, i'm a croaker kind of guy. this is in the irrational market. we punctuate by food news, events wally how a company is doing, it will impact stock for more than a day. hang tight. i'm highlighting a company that can be headed higher with the smokers. plus, caterpillar took wall street by surprise this morning with huge head funds. you absolutely need to know about this stock going forward. that's coming up. not all activists and investors, i'm telling you why activism isn't always the answer. oh, you will not want to miss my take on this one. so stick with cramer! (vo) what does the world run on?

it runs on optimism. it's what sparks ideas. moves the world forward. invest with those who see the world as unstoppable. who have the curiosity to look beyond the expected and the conviction to be in it for the long term. oppenheimerfunds believes that's the right way to invest... ...in this big, bold, beautiful world.

dentist appointment when my teeth are ready? ♪ can it tell the doctor how long you have to wear this thing? ♪ can it tell the flight attendant to please not wake me this time? ♪ the answer is yes, it can. so, the question your customers are really asking is, can your business deliver?

there's no question, this is really an ugly market. let's call it a bear market. right. >> that doesn't mean individual stocks can't work even in an individual environment. when the smoke clears, they will clear, no one will be susceptible to the pulse. as nike showed this very night, with a progress report. people can be way too negative. which means me to the curious case of a corporation and the most punished cohort outside natural resources, drug giant eli lilly. here's a company that's been a bit of a punching bag on wall street. i can actually say it's been a punching bag for years as you take a look at the last ten. all this continuing promising something in the pharmaceutical space and never delivering.

at least not until late. it shot up in a single session last thursday, with super positive diabetes data. the stocks up 25% year-to-date t. champ in the segment. that's some impressive performance. especially considering how the drug stock versus gone into freefall and biotechs get mauled day of day. i'm thinking it might be the reception you should buy in the weakness right now with this fueled by hillary clinton's anti-biotech tweet and the pounding of the overall stockmarket. so what exactly happened here? how is heck is eli lilly going to a market like ambien, frankly. the s&p 5002015? for years eli lilly struggled to get off the ground. for the last decade the stock has been languishing, thanks to a series of high profile expirations with no big drugs in the pipeline large enough to replace the block busters going generic. and last year was particularly

tough for lily as the company went over another patent clip. this the size of everiest as cimbalta. both went generic. the vast majority of their sales evaporated almost overnight. given that cynbalta was one of the related drugs in 2013. this was what we will call a suboptimal situation. eli lilly had not much to show for itself. so the stock did very little. starting this summer as the rest of the market lost it's footing. things started to turn around for eli lilly. to the point where it's the best performing big far ma stock ofa stock out there. resurgence is about two things, diabetes and alzheimer's, eli

lilly, both on the market and in the pipeline. the big story here is jarrdan. it makes you pea out excessive blood sugar jardian has a long stage free trial. it's tricky with cardio vascular help. we have the four outcomes. the data was a bombshell. we found out if you take jardians on top of the ordinary standard of care, you will see a significant, really major reduction in non-fatal heart attacks and strokes, not to mention a 38% reduction in cashedio vascular events that are actually fatal. this was just amazing. these results came out of nowhere. this study jardians is the only diabetes medication to show a

reduction if cardio vascular deaths in a data outcome trial. they suggest it could lead to a major increase if life expectancy for people with diabetes ii. what kind of impact could this have? i have seen analysts suggesting jardian has the potential to become a megablockbuster that could generate $6 billion in peak sales. in other words, they might up the game changing therapy for what we were waiting for. this isn't some pipeline drug that won't affect the numbers for years. jashdian is on the market. people are looking for four times the size we saw before one week. the other big contributor of the turnaround has to do with zolenza alzheimer's drug. they announced the pretrial which shows alzheimer's patients for 132 weeks had significantly better cognition and function than patients that started

taking it 24 hour hours later. it demonstrates that lily's drug can at the very least show some of the symptoms caused by alzheimer's. this is a food deal because it's such a difficult disease to treat with so few drug on the mark that do anything to help for a huge unfortunately huge in growing population of patients. put it altogether and after years where eli lilly didn't invent anything notable, coming two blockbuster drug in the form ofyardians for diabetes and zolenza for the epidemics around the world. merck down 10% for the years. even bristol-myers is up. merck yielding 3.'05 j & j and lily's paltry. what big investors really want

is grow, particularly in an environment like this one, where consistent growth is hard to come by. with one possible drug on the market and another in the pipe, eli legally has the potential for magnificent growth. in fact the company's diabetes and alzheimer's could have a string of data for not a few kwashters. not a fuf years, but many years to come. that's why lily's stock is sort of late and why it's currently trading four times next year's earnings estimates. those will prove way too low. i think you lily deserves that premium. we know the market has no problem paying out for companies with megablockbuster drugs. remember gilead after the hepp c cure. >> that is almost unheard of to have two block busters. i think it has a lot more upside. especially since it pulled back where it was after it reported the terrific diabetes drug last week. that's a steel. here's the bottom line. for years, eli lilly had to talk

down. they struggled to walk the walk. in recent months, they made one, not two quantum leaps forward and these are both gigantic addressable markets. littlely set itself apart from the rest of big far pharma. in an incredible market it opens down 260 points, lily is the big name in bigp harma. >> that can be the case for years and years to come. caterpillar has a shocking shortfall i'm telling you if it can claw it's way back. activists don't know best. i'm reviewing a time when meddling went way wrong just ahead. then, are people missing the big picture with optco. stick with cramer. at&t and directv are now one.

which means you can watch movies while you're on the move. sitcoms, while you sit on those. and even fargo, in fargo! binge, while you lose weight! and enjoy a good cliffhanger while you hang from a... why am i yelling? the revolution will not only be televised. the revolution will be mobilized. introducing the all in one plan. only from directv and at&t.

trying to start that, when i awoke at 4:00 a.m. this morning, wing willed to be a pretty strong load, futures positive. everything seemed to go bonkers in new york all at once, perhaps the auto industry refuses to roll over on emissions rigging could ascend to other car

companies. the sales is important. 70% of the german economy is related. next. you know, they're down and we're down with the addage. we reflect whatever is worse in the world right now. then things got horrendous when caterpillar announced a shocking shortfall of $1 billion in sales. more important layoffs as many as 10,000 people because of the shortfall as well as a weakness in markets. how are they honest? pointing out twice this is the third consecutive year of down sales, at this pace, 2016 could be the first time in its 90-year history. that's an astonishing fact. given that caterpillar has been through a leg of a lot of downturns. it makes plenty of sense. cat is at the epicenter of the old mining and manufacturing economy. in fact the weakness stems from markets like construction industries. resource industries and energy and transportation. which ruin the big three of what drives global growth.

how surprising was this announcement given caterpillar stock has been on a one-way down. china started making noises about economic weakness, caterpillar is one of the few american companies that have done fabulous, particularly coal. however the world has turned against coal, it's not coming back. so much is invested in material handling machines, this business is shrinking far faster than anyone thought possible. the machines needed to extract heavy oil from the ground, the kind of oil that doesn't make sense to produce at $45 prices, that business has been going away as oil stays lower longer. it seems to get worse. it's become much harder to borrow the money necessary t. clincher, though, comes from construction of equipment, which have been the lone bright spot in the troika. like the autos, the getting better was taking place domestically t. rest of the world is getting worse.

caterpillar's weakness confirms tremendous decline in various stocks come in for engines and walk the cranes, also dovetails on all things mining from coal to i-on-or copper -- iron or copper. what do you do with caterpillar down 6% on the session? all right. here's my bottom line. historically, i say when things get this ugly, you need to think of buying tan selling venlg i think the revenue of 48 billion down 1 billion from before today's announce p, it's way too optimistic given the horrid backdrop. >> that means the costs annually should not be able to offset the decline. so even though the stock is down 28% year-to-date with a 4% yield, cat remains a stock i don't want you to own. despite the fact the company produces the best big machines on ear it's. sometimes, though, it doesn't matter how good the product is, if your clients don't need it. that's certainly the case with

caterpillar's big yellow marbles. let's go to charlie in indiana. charlie. >> hi, jim. >> hey, charlie. >> caller: i'm interested in home building and kb home, in particular i want to know, whether to buy, hold or sell. >> i think kb home is okay. lennar is great. rlkb is down. lennar is a better situation. bob in pennsylvania. bab. >> caller: good afternoon, jim, i hope you are doing well today. >> i like to think i am. how about you? >> caller: doing good. i have been long to kansas city southern, jim, a month ago you said possibly they were going to be able to hold on to their revenue. i understand they pull oil out of canada, going down to the pork. but also they handle grain, jim, coming out of the mid-west. with the grain shortage now from

the crop damage, going down into mexico, do you still feel it's worthwhile to hold on, too? >> ksu has come down a great deal t. best business they have is the auto business out of members colorado i don't think you should sell ksu down here. i think it is, yes, indeed, too low. roger in new york. roger. >> caller: hey hi, jim. first time caller, long-time supporter. >> okay. >> caller: i wonder if i get your opinion on ge, what you think will happen over the next 12-to-24 hour months? it has been bouncing out the past two years. >> i think he is getting out of a lot of businesses, critically finance. but that said, people's 6% yield and nobody seems to care. one day they will. at that point ge stock will ignite. just not yet. but they're paying it away. sure, caterpillar's products are superb. unfortunately, no one seems to want them now. 48 billion. i don't know, i don't know if it can hold. much more "mad" ahead, including

steel, it's one of the heaviest metals. i'm taking a closer look. then opko's stock has been anything but healthy since june. don't miss my exclusive and your questions about this tough market. rapid fire in the liningening round. so stick with cramer.

selling 18 homes? easy. building them all in four and a half months? now that was a leap. i was calling in every favor i could, to track down enough lumber to get the job done. and i knew i could rely on american express to help me buy those building materials. there are always going to be unknowns. you just have to be ready for them. another step on the journey... will you be ready when growth presents itself? realize your buying power at open.com

in this environment, one of the few things that can get a stock roaring is the news that its activist investor has decided to get involved, either working with management or straight up bullying them in order to unlock value. there are a lot of smart actistists who tend to be terrific for long-term

shareholders. it's important to remember activism doesn't always lead to positive results. in fact, some of the investors turn up to be dead wrong and their meddling actually destroys value. how can you tell when the activists are going too far? let me explain with a story t. cautionary tale of timkin. which, frankly, has been wrecked, by people who didn't know as much as they thought. timkin was a classic cyclical stock. a maker of high performance and allow steel as well as various mechanical components. it got slammed in the great depression. by mid-2011 it rallied back to all time high, thanks, to the economy and a menu of steel products. however, businesses began to slow, amid unlike economic uncertainty. stocks started trading sideways. that's when the activists passed. in late 2012, timkin came under siege from investors a and the california state teacher's retirement fund. their demands, they wanted

timkin to break itself up into two separate companies, one for highly engineering mechanical components and one of a commodity steel maker. timkins' management was against the breakup t. activists smelled blood. the company had a number of other key characteristics that activists investors like to seize on. for starters, timkin was basic ally still a family company. the family controlling three of the 11 board seats, including the chairman position. this let the activists at relation cry foul and imply the family wasn't looking out for other share holders. they claim timkin wasn't under value and their closest competitor, a swedish company spun off several years before that, it worked out well for everyone. at the timkin was trading in the mid-50s the activist suggested based on the sum of the parts analysis, sotp, it could be worth closer to $71 in the event of a break-up. however, management insists the company was the wrong way to go. it would be very risky to

separate the secular car from the cyclical supplier. they said they could create more value with a single entity and the combined company can hold up much better in the event of a global downturn. the pipe became very heated. on my 1st, timkins' then ceo jim griffith came on "mad money" to make his case against the script. he argued they were keeping the finished products and raw materials business under the same roof. he said it allowed him to take knowledge and apply it across the whole company. which is why timkin outbought the earnings power. on top of that, real benefits on the scale of the combined company. the benefit would be lost if timkin broke up. for example, griffin came on the show. he pointed out a sizable chinese sales came from relations that have been built up by their manufacturing becomes. so what would happen if they

broke up the company? here's the reply on "mad money". >> that business would conceivably go away from the high profile proprietary business if you separated them. that's correct, it would be difficult to leverage the synergies of a global company if, in fact, we split the two companies in half. >> whew, that's subtle. timkin feels sorry having a more diversified business model allows them to support each other in times of weakness, like we're having now. here's how griffin put it when he came on the show. >> i feel that the companies that are doing worse in your industry when you look at the returns, ak steel, u.s. steel, they tends to be the companies that you would debt if you did a split-up where you would jump the company up, puts one place with commodity and think you could bring out value somehow by creating that company. >> yeah, again, those are companies that focus on manufacturing steel. timkin used to be one of those companies. today we focus on what we know

and leveraging it to create value. >> that creates top earnings margins, return on invested capital and obviously from a shareholder point of view, top return to our shareholder. >> however the activists didn't seem to be listening to that. after we get through that interview, they held a voter relational non-binding proposal to spin off the steel business. the activists won that vote 53-47%. in response, timkins' board said they'd take it under consideration, under pressure from the shareholders, they set up a tragedy, hiring goldman sax with the evaluation wow, goldman sided with the activists, said it would be better than staying in one piece. goldman decided and the family had been a great stew ward. finally september 5th 2013, timkins' board of directors caved in and asked if the kane would spin off the steel businesses, at the time jim

griffith the ceo that fought so aggressively announced he would retire the moment the spin-off was complete. in july of last year, timkin spun off a separate entity. what's happened since then? after an nish spike, both stocks have been absolutely annihilated. including a hideous 20% decline after the company slashes guidance a week and a half ago so how much has this breakup destroyed? let's see, timkin was trading at $67 and change as of his last day on the combined company. shareholders got one share for every two shares in timkin. it is today a $27 stock. timkin steals an $11 stock. few own it right before the breakup to today. you are down roughly 50%. yet this breakup that reeblgsal investors has, instead, created the value, let's just say of a

company cut in half. what went wrong? basically, all former ceo's arguments on "mad money," all of his warnings about the dangers and the brangup, they turn out to be true. what a surprise the company's ceo knew what he was talking about. since the breakup, markets have fallen apart. the two smaller weaker companies haven't been able to weather the storm on their own. the deal maker fell off a cliff, now timkin is an ailing steel company rather than being a provider of valuable relevant for business in the service business. and the worst part, the activist relational investors didn't stick around to see how it would work. they sold a big chunk of the timkin position in the second quarter of 2014 right before the breakup, unloaded the rest in the third quarter, despite the spin-off. they may have bailed for a host of reasons. i still say ouch. here's the bottom line. just because activist investors get involved with a particular company, that doesn't necessarily mean they will create value.

int case of timkin, long-term shareholders were better off. sometimes the people running the company understand it much better than those allegedly brilliant money managers. who a shame for this great american manufacturer and the families that banned it so well for so many years. what a crying shame? "mad money" is back after this.

a quick programing hotel in. don't miss my friend john chen, that would be tomorrow on "squawk" alley and now it is time, it is time for the lightning round. this is where we say whether to buy, buy, buy, or sell, sell, sell. then the lightning round is over. are you ready, ski dad city in time to start on the lightning round, dave in pennsylvania. dave. >> my stock is cyprus semi-conductor. how are we doing? >> the yield is what can i say? it's a bear market. it's a keep stock. i can't back away with that yield. let's go to scott in virginia. scott. >> jimmy, talk to me about blue

buffalo. should i be a part of the? >> no, we looked eight. it's expensive versus the growth rate. how about john in wisconsin. >> caller: yeah, boo-yah, jim. my stock is huntsman. i'm wondering, buy, sell or hold? this stock is selling so much. the huntsman is a decent chemical company. people must beat the earnings, in part. you should wait, it yields 3.5. let's go to dave in illinois. >> jim, they know nothing cramer. >> there you go. >> caller: raddious health? >> i think radius is great. they almost can be called a miracle drug. i think it's terrific. i want you to buy it. >> let's go to mike in virginia. mike. >> cramer, boo-yah to you, baby. >> how are you?

>> caller: i'm doing great. i'm doing great. i want to talk to you about your investment group. what do you think about -- >> i'm woirksd i see that 9% yield. most companies can't sustain it. i will say hey, i don't know. doug in mississippi. >> caller: ye, hey, jim. >> how are you? >> caller: i'm good, jim, i'm good. are you okay? >> yeah, i'm doing great. what's going on? >> caller: thank you for all you do. thank you for taking my call. i bought yahoo 44. should i hold it? >> yahoo is tradings like ali baba, it goes down, yahoo has a core business fought being valued at all. i'm not against that stock him mike in oklahoma. mike! caller yeah, jim, thanks, for taking my call. >> excellent. >> caller: what dunk of ibm? >> have you noticed ibm is no longer going down, warren buffet has a big holding in it. i think it's way too satellite sell ibm.

3.6% yield, you know what i think it's getting attractive. marianne in connecticut. marianne! marianne? >> caller: yes. >> you are up. >> caller: i'm calming about aqua america with the changes in the upper management with benedictus, the chairman of the board and the other guy going up the corporate ladder. do you see any likelihood that there is going to any changes? >> not much. i think it's a kind of expensive stock. i prefer a coned at %. either that or i like dominion. >> that, ladies and gentlemen, is the conclusion of the lightning round. >> the lightning round is spored by -- td ameritrade. random? no it's all about understanding patterns like the mail guy at 3:12 every day or jerry, getting dumped every third tuesday. this happens every third tuesday. we have pattern recognition technology on any chart,

plus over 300 customizable studies to help you anticipate potential price movement. there's no way to predict that. for all the confidence you need. td ameritrade. you got this.

all right. what next happened to opko health? it has a major side line in making a diagnostics test. the stock was up 90% year-to-date, based on the diagnostic and pharmaceutical business. in the last month it traded from 19 to nine dollars and change turning negative for the year. the reason? it announced a full service clinical laboratory company bioreference laboratories for $1.7 billion in an all stock transaction. we know wall street got turned

off by the deal. the stock sank the day it was announced. the stock has been going lower ever since. that's why tonight i want to give opko to make the indication. it's smart and the ceo is among the smartest people i know. let's take a closer look with dr. philip frost the chairman and ceo at opko health. hear more. dr. frost, welcome back to "mad money." >> thank you, jim. a pleasure to be here. >> eunderstand immun no therapy and the break-through drugs, so much of research depends on laboratories and actually having data. bioreference lab was probably the best at it. i give the floor to you to explain to me why the deal makes so much sense? >> first of all, let me say in all my years of being in the pharmaceutical business, this is probably the best and most interesting acquisition i've ever made. first of all, we realized a 14% delusion in our equity with this

acquisition. what did we get? we got a billion dollars in revenues. approximately $100 million on operating income and we have access to a sales force and infrastructure that will help make our 4k score test one of the post-important tests in the history of the diagnostics business. it has that potential. >> and you should explain to people. because this is a nationwide fabulous test that you expect millions of people to take. >> exactly. so you can just imagine there are 30 million psas done on men every year in the united states, of which, approximately, 4 million are elevated. now, every one of those is a candidate to have a 4k score test on it to confirm the importance of the elevated psa. and with a positive 4k score, you then can evaluate whether or

not you want to go on to a biopsy, which might have been done in any case if you had relied on the psa alone. now, with this 4k score, it has been shown in over 10,000 men in o12-year period with ten publications and peer review journals, that you can eliminate approximately 50% of the biopsys with all te atending side effects, such as infection and bleeding and worse. and the costs of the health care system is certainly about to benefit from all of this. so this is an important test and the bioreference acquisition with her 400 salesmen who will not only call a urologist as we are presently doing, are calling on primary care physicians to widely increase the range of physicians who will have access to the texts? >> i mean, what i also think we hear from a lot of companies that say, look if we had the data from lab, we would do much better. we hear from the biotechs

saying, look, we need genomic medicine, personal medicine, bioreference is one of these companies that does it. >> well, now that you mention it, i should say that 25% of the revenues of bioreference laboratories comes from the genomic testing. and they have the largest menu of tests for rare diseases in the whole industry. and with a 25% of the revenues that that rort represents, it's still growing rapidly. so that part of the business is in its infancy. it's a very sophisticated business, because they had been accumulating very valuable data on over 250,000 tests at 125,000 patients. that data will be important for other companies, drug companies, that are interested in using it to identify targets for new drug as well as to help diagnose rare diseases. >> let me just ask you, we're running short of time. you were a huge buyer of your

stock, you have been a buyer. is this level intriguing to you as a personal investor? that's what i followed you as all my career. >> i am very happy to continue my investment program in opko. i have always been a believer in investing in the stocks with which i'm connected. because it's hard for me to imagine is asking other people to invest when i don't myself. >> have you been buying at this level? >> absolutely. as recently as yesterday. >> wow. all right. look, i think you made a compelling case. i thought it was a brilliant acquisition myself. i knew it went down and up and thank you four coming on to "mad money." >> my pleasure there that's the chairman of opko health. he remains a believer. i think this stock is way over punished given the synergies between bioreference and opko. stay with cramer. at&t and directv are now one.

which means you can watch movies while you're on the move. sitcoms, while you sit on those.

and even fargo, in fargo! binge, while you lose weight! and enjoy a good cliffhanger while you hang from a... why am i yelling? the revolution will not only be televised. the revolution will be mobilized. introducing the all in one plan. only from directv and at&t. all right. are they needles in the hay stak, these stocks doing well, companies doing well. i don't think so. but you know what, you have to work hutch harder to find them. case in point. nike. no one thought nike could make the numbers. they could, they did well in china. there is always a market somewhere. i promise to find it for you. i'm jim cramer. see you tomorrow.

l-that was pretty good. -mike: [ laughs ].. lemonis: ...a custom drum company can't find the rhythm to meet supply and demand. mike: our turnaround time is six to seven months. -lemonis: six to seven months? -mike: yeah. that's created a backlog of unpaid bills and serious cash-flow problems. chris: we don't have enough money to cover payroll for next week. lemonis: i mean, you're kind of closed. chris: yeah. lemonis: the owner and his right-hand man are out of sync. louie: the lack of communication, i think, between chris and mike, it's like -- it's just...exactly. lemonis: and the two brothers who started this business have split up... scott: what did i ever do to you? mike: i really don't want to get into all that. lemonis: ...causing a whole nother layer of crippling issues. if they can't fix their process and their relationship... mike: fixing the business and this [bleep] is hard enough. lemonis: ...they'll be forced to close their doors forever.